Clinical Trial Update: Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating rehabilitative protocols in progressive multiple sclerosis patients treated with anti-CD20 monoclonal antibodies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Anti-CD20 monoclonal antibodies

Snippet

Sponsor: University of Pavia | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED